Article
Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
Oncotarget - 15 Mar 2016
Yang Zongguo, Zhuang Liping, Lu Yunfei, Xu Qingnian, Tang Bozong, Chen Xiaorong
Abstract excerpt
Basal core promoter (BCP) A1762T/G1764A dual mutations in hepatocarcinogenesis remain controversial. Published studies up to June 1, 2015 investigating the frequency of A1762T/G1764A dual mutations from chronic hepatitis B virus (HBV) infection, including hepatocellular carcinoma (HCC), were systematically identified. A total of 10,240 patients with chronic HBV infection, including 3729 HCC cases, were included...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
